Stay updated on Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial
Sign up to get notified when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.
Latest updates to the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check23 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check52 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check60 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check74 days agoChange DetectedThe website has added new features while removing extensive options for downloading study data, including various file formats and detailed data fields.SummaryDifference4%
Stay in the know with updates to Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.